Chromosomal interactions regulate genome functions, such as transcription, via dynamic chromosomal organization in the nucleus. In this study, we identified genomic regions that physically bind to the promoter region of the Pax5 gene in the chicken B-cell line DT40, with the goal of obtaining mechanistic insight into transcriptional regulation through chromosomal interaction. Using insertional chromatin immunoprecipitation (iChIP) in combination with next-generation sequencing (NGS) (iChIP-Seq), we found that the Pax5 promoter bound to multiple genomic regions. The identified chromosomal interactions were independently confirmed by in vitro engineered DNA-binding molecule-mediated ChIP (in vitro enChIP) in combination with NGS (in vitro enChIP-Seq). Comparing chromosomal interactions in wild-type DT40 with those in a macrophage-like counterpart, we found that some of the identified chromosomal interactions were organized in a B cell-specific manner. In addition, deletion of a B cell-specific interacting genomic region in chromosome 11, which was marked by active enhancer histone modifications, resulted in moderate but significant down-regulation of Pax5 transcription. Together, these results suggested that Pax5 transcription in DT40 cells is regulated by inter-chromosomal interactions. Moreover, these analyses showed that iChIP-Seq and in vitro enChIP-Seq are useful for non-biased identification of functional genomic regions that physically interact with a locus of interest.
Introduction
Elucidation of the molecular mechanisms underlying genome functions, such as transcription, requires identification of molecules that interact with the genomic regions of interest. To this end, we developed locus-specific chromatin immunoprecipitation (locus-specific ChIP) technology [see review (Fujita and Fujii 2013b; Fujii and Fujita 2015; Fujita and Fujii 2016) ].
Locus-specific ChIP is a biochemical tool for specifically isolating genomic regions of interest from cells. In combination with downstream biochemical analyses, one can identify molecules that physically interact with target genomic regions in cells.
In principle, locus-specific ChIP consists of locus-tagging and affinity purification.
On the basis of various strategies for locus-tagging, we developed two locus-specific ChIP technologies, insertional ChIP (iChIP) (Hoshino and Fujii 2009; Fujita and Fujii 2012a) and engineered DNA-binding molecule-mediated ChIP (enChIP) (Fujita and Fujii 2013a; . iChIP utilizes an exogenous DNA-binding protein, such as a bacterial protein LexA, and its binding element for locus-tagging, whereas enChIP employs engineered DNA-binding molecules, such as transcription activator-like (TAL) proteins (Moscou and Bogdanove 2009; Boch et al. 2009 ) and the clustered regularly interspaced short palindromic repeats (CRISPR) system (Jinek et al. 2012; Cong et al. 2013 ), for the same purpose. After isolation of tagged loci by affinity purification, their interacting molecules can be comprehensively identified by downstream analyses including mass spectrometry (MS), next-generation sequencing (NGS), and microarrays. In fact, we have successfully identified proteins that interact with target loci by iChIP or enChIP in combination with MS, including a quantitative form of MS, stable isotope labeling with amino acids in cell culture (SILAC) (iChIP/enChIP-MS or -SILAC) Fujii 2011a, 2013a; Fujita and Fujii 2014b; Fujita et al. 2015a ).
In addition, identification of chromatin-binding RNAs is also feasible using enChIP in 4 combination with RT-PCR (enChIP-RT-PCR) or RNA sequencing (enChIP-RNA-Seq) (Fujita et al. , 2015b . Genome functions are mediated by chromosomal interactions (e.g., interactions between enhancers and promoters). To detect physical chromosomal interactions, several techniques have been utilized to date, including fluorescence in situ hybridization (FISH) (Trask 1991) and chromosome conformation capture (3C) plus 3C-derived methods (Dekker 2002; Simonis et al. 2006; Dostie et al. 2006; Lieberman-aiden et al. 2009; Dekker et al. 2013) . In this regard, locus-specific ChIP can also be applied to detection of physical chromosomal interactions (one-to-many interactions). In fact, using iChIP in combination with microarrays (iChIP-microarray), McCullagh et al. succeeded in non-biased identification of genomic regions that interact with a target locus in yeast (McCullagh et al. 2010) . More recently, we showed that it is also feasible to analyze physical chromosomal interactions using enChIP combined with NGS analysis (enChIP-Seq) (Fujita et al. 2016b ).
The Pax5 gene encodes a transcription factor essential for B-cell lineage commitment (Cobaleda et al. 2007 ). Disruption of the Pax5 gene inhibits B-cell differentiation (Urbánek et al. 1994; Nutt et al. 1997) , and Pax5-deficient B cells can be trans-differentiated into other lymphoid cell types in mice (Nutt et al. 1999; Mikkola et al. 2002; Schaniel et al. 2002) . To obtain mechanistic insight into transcriptional regulation of the Pax5 gene, we previously used iChIP-SILAC to identify proteins that interact with the Pax5 promoter region in the chicken B-cell line DT40 (Fujita et al. 2015a ). However, the mechanisms underlying regulation of Pax5 transcription by chromosomal interactions remain incompletely understood. Although intron 5 of the mouse Pax5 gene contains enhancers essential for transcription of the gene (Decker et al. 2009 ), it remains unclear whether similar regulatory mechanisms exist across species. In this regard, because the DNA sequences of Pax5 intron 5 are scarcely conserved between mouse and chicken, it is possible that transcription of Pax5 is controlled in a species-specific manner.
In this study, we applied iChIP in combination with NGS analysis (iChIP-Seq) to direct identification of genomic regions that interact with the Pax5 promoter region in DT40 cells. Some of the detected chromosomal interactions were independently confirmed by an updated form of enChIP-Seq. In addition, deletion of a B cell-specific interacting genomic region significantly decreased Pax5 transcription in DT40 cells, suggesting that the deleted region is an enhancer and that Pax5 transcription is regulated through chromosomal interactions between this enhancer and the promoter. Thus, locus-specific ChIP in combination with NGS analysis revealed a mechanism of transcriptional regulation of the chicken Pax5 gene.
Results and Discussion

Scheme of iChIP-Seq for analysis of chromosomal interactions around the Pax5
promoter region
The scheme of iChIP-Seq used in this study is as follows ( Figure 1A In this study, we utilized DT40-derived cell lines ( Figure 1B ), which were previously established for iChIP-SILAC analysis of the Pax5 promoter region (Fujita et al. s2015a ); Non-KI(B) is DT40 expressing 3xFNLDD, and KI(B) is a DT40-derived cell line harboring an insertion of LexA BE in the Pax5 promoter region and expressing 3xFNLDD. In our previous study, insertion of LexA BE and expression of 3xFNLDD did not disturb transcription of the endogenous Pax5 gene (Fujita et al. 2015a ), suggesting that the regulatory machinery involved for Pax5 transcription is retained in both Non-KI(B) and KI(B). In addition, we previously showed that the Pax5 promoter region can be efficiently isolated from KI(B) by iChIP (~10% of input as DNA yields) (Fujita et al. 2015a ). Following the experimental scheme ( Figure 1A) , we isolated the Pax5 promoter region by iChIP and subjected the purified DNA samples to NGS analysis using a HiSeq. NGS reads Figure 1C ]. A biological replicate of the iChIP-Seq analysis showed similar results [iChIP(#2) in Figure 1C ]. These results demonstrated efficient isolation of the Pax5 promoter region by iChIP.
Detection of genomic regions that physically interact with the Pax5 promoter region in DT40
Next, we proceeded to identify the genomic regions that interact with the Pax5 promoter region in DT40 ( Figure 2 ). Because 3xFNLDD might interact with endogenous DNA sequences, similar to the recognition sequence of LexA (CTGTN 8 ACAG) (Walker 1984) in the DT40 genome, iChIP-Seq data obtained from Non-KI(B) were used to eliminate genomic regions detected due to such off-target binding (Step 1 in Figure 2 ). We identified 2,383 peak positions with read numbers more than 2-fold higher in KI(B) than in Non-KI(B), and considered these as potential interacting genomic regions. Because the top 5% peaks (119 peaks) had >7-fold enrichment (Step 1 in Figure 2 ), we arbitrarily set 7-fold as the threshold for extraction of genomic regions that interact with the Pax5 promoter region with high frequency. As shown in Step 2 in Figure 2 , 105 peaks passed this criterion (>7-fold), from among 2,325 peaks (>2-fold) in the biological replicate. Comparing the 119 (Step 1) and 105 ( Step 2) peaks, we identified 34 peaks as reproducibly passing the criterion (Step 3 in Figure 2 and Supplementary Table S1 ). Among the 34 peaks, 1 peak was the LexA BE-inserted Pax5 promoter region ( Supplementary Table S1 ) and the other 33 were considered as candidate genomic regions that physically interact with the Pax5 promoter region.
In this study, we filtered iChIP-Seq data on the basis of the criterion "greater than 7-fold" to extract genomic regions that bind to the Pax5 promoter region with high frequency.
In this regard, more permissive criteria would increase the number of potentially interacting 33 peaks* and the target region ( Supplementary Table S1 ) 1 peak in chromosome 5 3 peaks in chromosome 11 29 peaks in chromosome 21 *Distribution of the 33 peaks 8 genomic regions. In fact, the criterion "more than 2-fold" extracted 680 common peaks between the 2,383 peaks (Step 1) and 2,325 peaks (Step 2). However, in this case, it might be more difficult to confidently evaluate whether the detected peaks reflect physiological interactions or artificial signals. Therefore, hereafter we focused on the 33 peaks passing the more stringent criterion.
Confirmation of physical chromosomal interactions by in vitro enChIP
The chromosomal interactions identified by iChIP-Seq ( Figure 2 ) could include artificial ones caused by insertion of LexA BE. Therefore, it was necessary to confirm the identified chromosomal interactions by another independent method in intact DT40 cells. To this end, we utilized in vitro enChIP, an updated form of conventional enChIP (Fujita and Fujii 2014a; Fujita et al. 2016a ). In in vitro enChIP, recombinant molecules [e.g., recombinant CRISPR ribonucleoproteins (RNPs)] are used for in vitro locus-tagging rather than in-cell locus-tagging ( Figure 3A ). Because intact cells can be utilized in this in vitro system, it is unnecessary to consider disruption of physiological chromosomal conformation and potential side-effects caused by in-cell locus-tagging. In in vitro enChIP using CRISPR RNPs ( Figure   3A ), chromosomal conformation in intact DT40 was fixed by formaldehyde crosslinking, and chromatin DNA was fragmented by sonication. The Pax5 promoter was captured by CRISPR RNPs and isolated from a mixture of the fragmented chromatin by affinity purification. NGS analysis of the isolated material then revealed the genomic regions that physically interact with the Pax5 promoter.
We designed a guide RNA (Pax5 gRNA) recognizing a 23 bp target site that is 0.1 kb upstream from the TSS of Pax5 exon 1A ( Figure 3B and Supplementary Figure S1 ); the recognized DNA sequence exists only in the target site, i.e., nowhere else in the chicken genome. We performed in vitro enChIP with Pax5 gRNA to specifically isolate the Pax5 Figure S1 ). Next, we examined whether the 33 peaks identified by iChIP-Seq (Step 3 in Figure 2 ) were also observed by in vitro enChIP-Seq ( Figure 3D ). Based on visual confirmation in Integrative Genomics Viewer (IGV), a high-performance visualization tool, approximately half of the peaks (14 peaks) were also observed by in vitro enChIP-Seq in the presence of Pax5 gRNA but not in the absence of gRNA (Table 1 and Supplementary Table S1 ); representative results are shown in Figure 4 and Supplementary Figures S2 and S3 . CRISPR binds to DNA sequences similar to the target sequence, a phenomenon known as off-target binding (Wu et al. 2014; Cencic et al. 2014; O'Geen et al. 2015; Tsai et al. 2015) . However, potential off-target binding sites were not found in the 14 identified genomic regions (Supplementary Figure S4) .
Thus, the genomic regions independently confirmed by in vitro enChIP-Seq (Table 1) Interestingly, most of the identified genomic regions were localized in chromosome 21 (Table 1 and Supplementary Table S1 ). Because those regions were spread equally in chromosome 21 ( Supplementary Figure S5 Figure S6) , iChIP can capture chromosomal interactions organized in the more upstream region of the Pax5 promoter, whereas in vitro enChIP might fail to confirm such chromosomal interactions.
Identification of genomic regions that physically interact with the Pax5 promoter region in a B cell-specific manner
The chromosomal interactions identified above might be organized in a B cell-specific manner or occur constitutively in different cell types. Therefore, we next examined whether the 14 interacting genomic regions (Table 1) Figure 5A) (Fujita et al. 2015a) . As shown in Figure 5B , the Pax5 promoter region was isolated from KI(MΦ) by iChIP. Visual comparison in IGV revealed that three peaks in chromosome 11 and three peaks in chromosome 21 (total six peaks) were observed in a B cell-specific manner, whereas the other eight peaks were constitutively observed both in the B-cell and the macrophage-like cell lines (Table 1) ; the three B-specific peaks in chromosome 11 and two constitutive peaks in chromosome 21 are shown as representatives in Figure 5D -F and Supplementary Figure S7 , respectively. Thus, by comparing iChIP-Seq data, we were able to identify genomic regions that interact with the Pax5 promoter region in a B cell-specific manner.
We also attempted in vitro enChIP-Seq with the macrophage-like cell line Figure S8D ), suggesting that the CRISPR RNP was unable to access the gRNA target site.
Because Pax5 transcription is silenced in DT40(MΦ) ( Supplementary Figure S8B) , the Pax5 promoter might be heterochromatinized. Alternatively, effector molecules, such as transcriptional repressors, might occupy the gRNA target site, which would block access by the CRISPR RNP.
Regulation of expression of Pax5 by a physical interaction between genomic regions
The identified genomic regions (Table 1 ) might include transcriptional regulatory regions that control Pax5 transcription through chromosomal interactions. To examine this possibility, we used CRISPR-mediated genome editing to delete genomic regions that B cell-specifically interacted with the Pax5 promoter region (Jinek et al. 2012; Cong et al. 2013) . We chose the three regions in chromosome 11 for locus deletion because they are within 100 kb of each other, and it was therefore feasible to delete all of them at once ( Figure 6A ), and two of those regions are highly ranked in Table 1 . We refer to these three regions (Chr11: 8, 547, 551, 932; Chr11: 8, 566, 576, 125; and Chr11: 8, 646, 648, 734) as Interacting Region in Chromosome 11 No. 1 (IRC11-1), IRC11-2, and IRC11-3, respectively (Table 1) .
We constructed plasmids for expression of single guide RNAs (sgRNAs) targeting each end of those genomic regions ( Supplementary Figure S9A -C) and co-transfected them with a Cas9 expression plasmid to delete the target genomic regions (Supplementary Figure S9) . We were able to delete all three regions (100 kb) in one allele in DT40 ( Figure 6B and Supplementary Figure S9D and S10). In the resultant cells (Clone 100k), the transcript levels of the Pax5 gene were not changed ( Figure 6C and D) . Next, we deleted each interacting genomic region (IRC11-1, IRC11-2, or IRC11-3) in the other allele in Clone 100k ( Figure 6B and Supplementary Figures S9D and S10) . Additional deletion of IRC11-2 or IRC11-3 did not have any effects on Pax5 transcription, whereas deletion of IRC11-1 moderately but 547, 551, 932) 14 kb 70 kb 100 kb 566, 576, 125) IRC11-3 (8, 646, 648, 734) Chr 11 A Figure 6 (Figure 6C and D) . In DT40, Pax5 was transcribed comparably from the exons 1A and 1B (Fujita and Fujii 2011b) . Deletion of IRC11-1 decreased transcription from exon 1A, but not 1B ( Figure 6C and D) . To further confirm the physiological importance of IRC11-1 for Pax5 transcription, we deleted only this region from both alleles in DT40 ( Figure 6B and Supplementary Figures S9E and S10) . The resultant cells (Clone IRC11-1) also exhibited reduced Pax5 transcription from the exon 1A
( Figure 6C and D) . Thus, the decrease in levels of Pax5 transcription in two independently established cell lines (Clone 100k_IRC11-1 and Clone IRC11-1) suggested that IRC11-1 is involved in transcriptional regulation of the Pax5 gene, acting as an enhancer via inter-chromosomal interaction.
Active enhancers are marked by enrichment of histone H3 lysine 4 mono-methylation (H3K4me1) and histone H3 lysine 27 acetylation (H3K27ac) (Heintzman et al. 2007 (Heintzman et al. , 2009 Creyghton et al. 2010; Kimura 2013) . We therefore investigated whether IRC11-1 is marked by these histone modifications. Because two peaks were observed in IRC11-1 by iChIP-Seq analyses ( Figure 4A and Supplementary Figure S2A ), we examined these histone modifications at both positions. ChIP assays clearly showed that these histone modifications were enriched at both positions in IRC11-1 but not in an irrelevant genomic region in chromosome 2 (Figure 7 ), suggesting that IRC11-1 functions as a distal enhancer for Pax5 transcription. Enrichment of the active enhancer marks was also observed in IRC11-3, whereas only H3K4me1 was enriched in IRC11-2 ( Figure 7) . Therefore, IRC11-3 might be involved in transcriptional regulation of genes other than Pax5.
Deletion of the 100 kb region including IRC11-1 in one allele did not have any effects on Pax5 transcription (Clone 100k in Figure 6D ). Because chromosome Z, which contains Pax5, is a single-copy chromosome in DT40 (Sonoda et al. 1998; Chang and Delany 2004) , IRC11-1 in each allele may be sufficient for transcription of the single-copy Pax5 gene. (2) Figure 7 13
In addition, deletion of IRC11-1 significantly but only partially down-regulated Pax5
transcription, suggesting that it plays a limited role in Pax5 transcription. In IRC11-1, two subregions, which are marked by H3K4me1 and H3K27ac, interacted strongly with the Pax5 promoter (two peak positions in Figure 4A and Supplementary Figure S2A ), suggesting that each subregion might work independently or collaboratively to regulate Pax5 transcription from exon 1A. Future work should seek to elucidate the mechanistic details underlying transcriptional regulation of Pax5 by IRC11-1.
Conclusions and perspectives
In this study, we identified physical chromosomal interactions between the Pax5 promoter and other genomic regions by locus-specific ChIP in combination with NGS analysis.
iChIP-Seq and in vitro enChIP-Seq revealed that the Pax5 promoter binds to multiple genomic regions, in which most regions are localized in chromosome 21 (Figures 1-4) . Some of these interactions were organized in a B cell-specific manner ( Figure 5 ). In addition, we showed that deletion of an interacting genomic region in chromosome 11, which is marked by active enhancer histone modifications, decreased transcriptional levels of the Pax5 gene ( Figures 6 and 7 ), suggesting its physiological involvement in transcriptional regulation of the Pax5 gene. Our results also indicate that locus-specific ChIP in combination with NGS analysis is a useful tool for performing non-biased searches for physical chromosomal interactions (one-to-many interactions). Thus, this technology could facilitate elucidation of the molecular mechanisms underlying regulation of genome functions, including transcription.
Several methods have been utilized for detection of genome-wide chromosomal interaction. However, observation by only a single method might not accurately reflect physiological chromosomal interactions. In this regard, potential discrepancies have been 14 reported between the results of FISH and those of 3C or its derivatives (Williamson et al. 2014) . Therefore, in analysis of chromosomal interactions, it may be necessary to combine several independent methods to eliminate potential contamination of artifactual signals. In this regard, iChIP-Seq and in vitro enChIP-Seq could be used as one of several methods. In this study, we used in vitro enChIP-Seq to confirm the results of iChIP-Seq. Considering its convenience, in vitro enChIP-Seq may be preferable for future identification of chromosomal interactions.
Materials and Methods
Plasmids
The Cas9 expression plasmid (Addgene #41815) and chimeric sgRNA expression plasmid (Addgene #41824) were provided by Dr. George Church through Addgene. For construction of the sgRNA expression plasmids, double-stranded DNA (dsDNA) encoding the target sequences were cloned downstream of the U6 promoter in the sgRNA expression plasmid.
Alternatively, DNA fragments coding the U6 promoter, target sequence, gRNA scaffold, and termination signal were synthesized and cloned in plasmids by GeneArt gene synthesis services (ThermoFisher Scientific). The target sites of each sgRNA plasmid are shown in Supplementary Figure S9C .
Cell culture DT40, Non-KI(B), KI(B), and KI(MΦ) were maintained as described previously (Fujita et al. 2015a ).
iChIP-Seq, in vitro enChIP-Seq, and bioinformatics analysis
Non-KI(B), KI(B), and KI(MΦ) (2 × 10 7 each) were subjected to the iChIP procedure as described previously (Fujita et al. 2015a) . DT40 was subjected to the in vitro enChIP procedure as described previously (Fujita et al. 2016a ). The complex of CRISPR RNA (crRNA) targeting the Pax5 promoter and trans-activating crRNA (tracrRNA) was used as Pax5 gRNA for in vitro enChIP. The gRNA sequences are shown in Supplementary Table S2 .
Briefly, after fragmentation of chromatin DNA (the average length of fragments was about 2 kbp), the target region was isolated by iChIP or in vitro enChIP. After purification of DNA, DNA libraries were prepared using TruSeq ChIP Sample Prep Kit (Illumina); in this preparation step, DNA fragments around 0.4 kbp in length were selectively concentrated. The libraries were subjected to DNA sequencing using the HiSeq platform according to the manufacturer's protocol. NGS and data analysis were performed at the University of Tokyo as described previously (Yamashita et al. 2011; Seki et al. 2014) . Additional information on NGS analysis is provided in Supplementary Table S3 . NGS data were mapped onto the reference genome galGal4 using ELAND (Illumina). Narrow peaks of each iChIP-Seq dataset (Steps 1 and 2 in Figure 2 ) were detected using Model-based Analysis of ChIP-Seq 2 (MACS2, http://liulab.dfci.harvard.edu/MACS/) with default parameters. Images of NGS peaks were generated using IGV (http://software.broadinstitute.org/software/igv/). The accession number of the NGS data is DRA005236.
Deletion of genomic loci by CRISPR-mediated genome editing
DT40 cells (1 × 10 7 ) were transfected with a Cas9 expression plasmid (120 µg), sgRNA expression plasmids (120 µg) targeting each end of a target genomic region, and pEGFP-N3 (0.3 µg, Clontech) by electroporation using a Gene Pulser II (Bio-Rad) at 250 V and 950 µF.
One day later, GFP-positive cells were sorted and expanded individually. To confirm targeted locus deletion, genomic DNA was extracted and subjected to genotyping PCR with KOD FX (Toyobo). PCR cycles were as follows: heating at 94°C for 2 min followed by 30 cycles of 98°C for 10 sec, 60°C for 30 sec, and 68°C for 1 min. Primers used for genotyping PCR are shown in Supplementary Table S2 .
RNA extraction and quantitative RT-PCR
Extraction of total RNA and quantitative RT-PCR were performed as described previously (Fujita and Fujii 2012b) . Primers used in this experiment are shown in Supplementary Table   S2 . 
Figure legends
